3 results
Not approvedWill not start
Primary:* To prove the superiority of a 48-weeks treatment with 3.2 g/day delayedreleasephosphatidylcholine (LT-02) versus placebo for the maintenance ofremission in patients with ulcerative colitis (UC)Secondary:* To study safety and tolerability…
Approved WMOCompleted
Primary Safety Objective: To describe the safety profile of 20vPnC
Approved WMOCompleted
The effect of deep muscle relaxation on the abdominal working space during laparosopy, measured by MRI.